{"id": "1339833421212786689", "creation": 1608276155.0, "user_id": "1219090523811528705", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "The Peruvian government has authorized the resumption of clinical trials of a #COVID19 #vaccine developed by the #China National Pharmaceutical Group, or Sinopharm, after an \"adverse event\" in one of the volunteers was \"clarified,\" said Health Minister Pilar Mazzetti. https://t.co/C9tO8TL6qH", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#CHINA"]}